AIM
SGMO

Anchor Investment Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Anchor Investment Management’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-50
Closed -$599 – 972
2021
Q2 		$599 Hold
50
– – ﹤0.01% 933
2021
Q1 		$627 Hold
50
– – ﹤0.01% 934
2020
Q4 		$780 Buy
+50
New +$586 ﹤0.01% 887

Other funds holding SGMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Anchor Investment Management's SGMO Position: Q3 2021 in Review

Anchor Investment Management sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q3 2021, closing a stake of 50 shares — an estimated $599 sold.

Anchor Investment Management first reported a position in SGMO in Q4 2020 and held it in 3 quarters. The position peaked at $780 in Q4 2020. 193 funds tracked by Wall St. Rank hold SGMO as of Q3 2021.

  • Anchor Investment Management reported no remaining SANGAMO THERAPEUTICS INC position as of Q3 2021 after selling out during the quarter.
  • Anchor Investment Management sold 50 SANGAMO THERAPEUTICS INC shares in Q3 2021, an estimated $599.
  • Anchor Investment Management first reported a position in SANGAMO THERAPEUTICS INC in Q4 2020 and held it in 3 quarters.
  • Anchor Investment Management's SANGAMO THERAPEUTICS INC position peaked at $780 in Q4 2020.
  • 193 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q3 2021.

Based on Anchor Investment Management's 13F filing for Q3 2021, filed 2 Jan 2024.